BackgroundCheck.run
Search For

Rose M Ackermann, 7219530 180Th Ave, Tustin, MI 49688

Known as:
Rose Mueller Ackermann Rose M Ackerman

Rose Ackermann Phones & Addresses

Tustin, MI   

Farmington Hills, MI   

9600 Oak Pointe Ln, Northville, MI 48167    248-4370898   

Birmingham, MI   

9600 Oak Pointe Ln, Northville, MI 48167   

Social networks

Rose M Ackermann

Linkedin

Work

Company: Cerenis therapeutics Dec 1, 2007 Position: Director of analytical and formulation development

Skills

Biotechnology • Pharmaceutical Industry • Drug Discovery • Lifesciences • Clinical Trials • Gcp • Technology Transfer • Drug Development • Drug Design • Analytical Chemistry • Lc Ms • Chromatography • Sop • Elisa • Hplc • Gmp • Chemistry • R&D • Clinical Development • Pharmacology

Languages

English

Interests

Collecting Antiques • Home Improvement • Reading • Gourmet Cooking • Sports • The Arts • Home Decoration • Cooking • Gardening • Outdoors • Electronics • Crafts • Music • Movies • Collecting • Kids • Travel • Investing • Sports Memorabilia Collecting

Industries

Biotechnology
Get Report
Control this profile

Mentions for Rose M Ackermann

Rose Ackermann resumes & CV records

Resumes

Rose Ackermann Photo 19

Director Of Analytical And Formulation Development

Location:
9600 Oak Pointe Ln, Northville, MI 48167
Industry:
Biotechnology
Work:
Cerenis Therapeutics
Director of Analytical and Formulation Development
Skills:
Biotechnology, Pharmaceutical Industry, Drug Discovery, Lifesciences, Clinical Trials, Gcp, Technology Transfer, Drug Development, Drug Design, Analytical Chemistry, Lc Ms, Chromatography, Sop, Elisa, Hplc, Gmp, Chemistry, R&D, Clinical Development, Pharmacology
Interests:
Collecting Antiques
Home Improvement
Reading
Gourmet Cooking
Sports
The Arts
Home Decoration
Cooking
Gardening
Outdoors
Electronics
Crafts
Music
Movies
Collecting
Kids
Travel
Investing
Sports Memorabilia Collecting
Languages:
English

Publications & IP owners

Us Patents

Lipoprotein Complexes And Manufacturing And Uses Thereof

US Patent:
2012023, Sep 13, 2012
Filed:
Feb 6, 2012
Appl. No.:
13/367237
Inventors:
Jean-Louis Dasseux - Toulouse, FR
Daniela Carmen Oniciu - Toulouse, FR
Rose Ackermann - Northville MI, US
Assignee:
Cerenis Therapeutics Holding S.A. - Labege
International Classification:
A61K 38/17
C07K 1/113
C12N 5/10
C12P 21/00
C07K 14/775
A61P 3/06
B82Y 5/00
B82B 1/00
US Classification:
514 74, 514 11, 530359, 435325, 435 696, 428402, 977773, 977915
Abstract:
The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.

Lipoprotein Complexes And Manufacturing And Uses Thereof

US Patent:
2022036, Nov 17, 2022
Filed:
May 27, 2022
Appl. No.:
17/826659
Inventors:
- Balma, FR
Rose ACKERMANN - Northville MI, US
Daniela Carmen ONICIU - Toulouse, FR
Assignee:
ABIONYX PHARMA SA - Balma
International Classification:
A61K 38/17
C07K 1/04
A61K 45/00
A61K 47/50
A61K 38/18
C07K 14/775
Abstract:
The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.

Lipoprotein Complexes And Manufacturing And Uses Thereof

US Patent:
2019029, Oct 3, 2019
Filed:
Apr 29, 2019
Appl. No.:
16/397944
Inventors:
- Balma, FR
Rose ACKERMANN - Northville MI, US
Daniela Carmen ONICIU - Toulouse, FR
Assignee:
CERENIS THERAPEUTICS HOLDING S.A. - Balma
International Classification:
A61K 38/17
A61K 38/18
A61K 47/50
C07K 1/04
C07K 14/775
A61K 45/00
Abstract:
The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.

Lipoprotein Complexes And Manufacturing And Uses Thereof

US Patent:
2016009, Apr 7, 2016
Filed:
Oct 15, 2015
Appl. No.:
14/884115
Inventors:
- Labege, FR
Rose ACKERMANN - Northville MI, US
Daniela Carmen ONICIU - Toulouse, FR
Assignee:
CERENIS THERAPEUTICS HOLDING S.A. - Labege
International Classification:
A61K 38/17
Abstract:
The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.

Lipoprotein Complexes And Manufacturing And Uses Thereof

US Patent:
2015015, Jun 4, 2015
Filed:
Jul 17, 2014
Appl. No.:
14/334519
Inventors:
- Labege, FR
Rose Ackermann - Northville MI, US
Daniela Carmen Oniciu - Toulouse, FR
International Classification:
C07K 14/775
A61K 38/17
A61K 47/48
Abstract:
The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.

Lipoprotein Complexes And Manufacturing And Uses Thereof

US Patent:
2014021, Jul 31, 2014
Filed:
Dec 11, 2013
Appl. No.:
14/103686
Inventors:
- Labege, FR
Rose ACKERMANN - Northville MI, US
Daniela Carmen ONICIU - Toulouse, FR
Assignee:
Cerenis Therapeutics Holding S.A. - Labege
International Classification:
A61K 47/48
US Classification:
514 11, 530359
Abstract:
The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.

Possible Relatives

David S Ackermann  Debra J Ackermann  Dennis A Ackermann  Donna J Ackermann  Douglas A Ackermann  Edward H Ackermann  Eric Ackermann  Rose E Johnson  Rose S White  Rose M Jones 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.